Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Nov 1;34(31):3816-3817.
doi: 10.1200/JCO.2016.68.8010.

Response to "Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer"

Louise E Daly  1 , Aoife M Ryan  1 , Derek G Power  1
Affiliations
Comment

Response to "Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer"

Louise E Daly et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to L.E. Daly et al.
    Blauwhoff-Buskermolen S, de van der Schueren MAE, Langius JAE, Verheul HMW. Blauwhoff-Buskermolen S, et al. J Clin Oncol. 2016 Nov 1;34(31):3817. doi: 10.1200/JCO.2016.68.9364. J Clin Oncol. 2016. PMID: 27480150 Free PMC article. No abstract available.

Comment on

References

    1. Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol. 2016;34:1339–1344. - PubMed
    1. Stene GB, Helbostad JL, Amundsen T, et al. Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncol. 2015;54:340–348. - PubMed
    1. Rutten IJ, van Dijk DP, Kruitwagen RF, et al: Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle 10.1002/jcsm.12107 [epub ahead of print on March 7, 2016] - DOI - PMC - PubMed
    1. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–1547. - PubMed
    1. Rollins KE, Tewari N, Ackner A, et al: The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 10.1016/j.clnu.2015.08.005 [epub ahead of print on September 1, 2015] - DOI - PubMed